Drug for COVID-19 Patients

Drug for COVID-19 Patients Listen to the recording and answer the questions: Which university conducted the new study? University of Albany University of Albeny University of Alabany University of Elbany Where were the patients hospitalised? New Jersey New York New South Wales New Yorksville When was the drug tested? March May last year a month ago What kind of drug is the hydroxychloroquine? anti-malaria anti-depression anti-measless anti-SARS How many patients were in the study? 1400 14 140 14000 Did all the patients who received the drug get better? yes no hard to say maybe Listen once more and fill in the blanks: A new study conducted by researchers at the University of Albany found that patients, who were hospitalized in the New York area, did not benefit from hydroxychloroquine.Hydroxychloroquine is the anti-malaria drug which the US president, Donald Trump, repeatedly praised as a possible treatment for the coronavirus. In March, US authorities issued an emergency use authorization to let medical workers use the drug on certain COVID-19 patients.Researchers looked at more than 1,400 COVID-19 patients, and they found that the patients, who received hydroxychloroquine, did not get better or worse than the patients who did not receive it. The study is not considered conclusive because it did not fulfil all necessary criteria. The state of New York is currently conducting a randomized controlled trial on the drug.